Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies
Sponsored by Constellation Pharmaceuticals
About this trial
Last updated a year ago
Study ID
CPI 0610-05
Status
Completed
Type
Interventional
Phase
Phase 1
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended a year ago
What is this trial about?
Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of pelabresib
(CPI-0610) and the effect of pelabresib on QTc in patients with advanced malignancies
What are the participation requirements?
Inclusion Criteria
- 18 years of age or older
- Confirmed diagnosis of an advanced malignancy for which no effective standard treatment options are available
- Eastern Cooperative Oncology Group (ECOG) performance status of ≤2
Exclusion Criteria
- Chronic or active conditions and/or concomitant medication use that would prohibit treatment